BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 9726387)

  • 1. Comparison of 10-day sequential therapy with 7-day standard triple therapy for Helicobacter pylori eradication in inactive peptic ulcer disease and the efficiency of sequential therapy in inactive peptic ulcer disease and non-ulcer dyspepsia.
    Chan CC; Chien NH; Lee CL; Yang YC; Hung CS; Tu TC; Wu CH
    BMC Gastroenterol; 2015 Dec; 15():170. PubMed ID: 26635102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of 1 and 2 weeks of omeprazole, amoxicillin and clarithromycin treatment for Helicobacter pylori eradication: the HYPER Study.
    Zagari RM; Bianchi-Porro G; Fiocca R; Gasbarrini G; Roda E; Bazzoli F
    Gut; 2007 Apr; 56(4):475-9. PubMed ID: 17028126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Eradication of H pylori infection in a rural population: one-day quadruple therapy versus 7-day triple therapy.
    Zhang L; Shen L; Ma JL; Pan KF; Liu WD; Li J; Xiao SD; Lin SR; Classen M; You WC
    World J Gastroenterol; 2006 Jun; 12(24):3915-8. PubMed ID: 16804982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Eradication therapy for peptic ulcer disease in Helicobacter pylori-positive people.
    Ford AC; Gurusamy KS; Delaney B; Forman D; Moayyedi P
    Cochrane Database Syst Rev; 2016 Apr; 4(4):CD003840. PubMed ID: 27092708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Management of dyspepsia, gastroduodenal ulcer and Helicobacter pylori infection in primary care].
    Gené E; Calvet X; Azagra R; López T; Cubells MJ
    Aten Primaria; 2002 May; 29(8):486-94. PubMed ID: 12031222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of
    Seyyed Majidi M; Sanjari Pirayvatlou P; Rajabikashani M; Firoozabadi M; Seyed Majidi SA; Vafaeimanesh J
    Gastroenterol Hepatol Bed Bench; 2018; 11(1):15-19. PubMed ID: 29564060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. First-line therapy in Helicobacter pylori eradication therapy: experience of a surgical clinic.
    Özbalcı GS; Yürüker SS; Tarım İA; Çınar H; Polat AK; Özbalcı AB; Karabulut K; Erzurumlu K
    Ulus Cerrahi Derg; 2014; 30(3):133-7. PubMed ID: 25931914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simple patch closure for perforated peptic ulcer in children followed by helicobacter pylori eradication.
    Yildiz T; Ilce HT; Ceran C; Ilce Z
    Pak J Med Sci; 2014 May; 30(3):493-6. PubMed ID: 24948965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrated models of population pharmacokinetics and exposure response to optimize dosage regimen for anaprazole sodium in duodenal ulcer.
    Zhang L; Song L; Cui C; Wang C; Zhang Y; Yao X; Liu D
    Eur J Pharm Sci; 2024 Jul; 198():106781. PubMed ID: 38703917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clarithromycin Versus Metronidazole in First-Line
    Murata M; Sugimoto M; Mizuno H; Kanno T; Satoh K
    J Clin Med; 2020 Feb; 9(2):. PubMed ID: 32079208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Meta-analysis of the efficacy of lansoprazole and omeprazole for the treatment of H.pylori-associated duodenal ulcer.
    Zeng Y; Ye Y; Liang D; Guo C; Li L
    Int J Physiol Pathophysiol Pharmacol; 2015; 7(3):158-64. PubMed ID: 26823965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of Helicobacter pylori.
    Harris A
    World J Gastroenterol; 2001 Jun; 7(3):303-7. PubMed ID: 11819780
    [No Abstract]   [Full Text] [Related]  

  • 13. Lansoprazole: an update of its place in the management of acid-related disorders.
    Matheson AJ; Jarvis B
    Drugs; 2001; 61(12):1801-33. PubMed ID: 11693467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quadruple therapy for symptomatic spontaneous duodenal ulcer disease.
    Bateson MC
    Postgrad Med J; 2001 Jul; 77(909):447-50. PubMed ID: 11423595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Helicobacter pylori.
    Bateson MC
    Postgrad Med J; 2000 Mar; 76(893):141-4. PubMed ID: 10684322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence of duodenal ulcer healing after 1 week of proton pump inhibitor triple therapy for eradication of Helicobacter pylori. The Lansoprazole Helicobacter Study Group.
    Harris AW; Misiewicz JJ; Bardhan KD; Levi S; O'Morain C; Cooper BT; Kerr GD; Dixon MF; Langworthy H; Piper D
    Aliment Pharmacol Ther; 1998 Aug; 12(8):741-5. PubMed ID: 9726387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. One week triple therapy for Helicobacter pylori: a multicentre comparative study. Lansoprazole Helicobacter Study Group.
    Misiewicz JJ; Harris AW; Bardhan KD; Levi S; O'Morain C; Cooper BT; Kerr GD; Dixon MF; Langworthy H; Piper D
    Gut; 1997 Dec; 41(6):735-9. PubMed ID: 9462204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lansoprazole and secnidazole with clarithromycin, amoxycillin or pefloxacin in the eradication of Helicobacter pylori in a developing country.
    Ahuja V; Dhar A; Bal C; Sharma MP
    Aliment Pharmacol Ther; 1998 Jun; 12(6):551-5. PubMed ID: 9678815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prolonging proton pump inhibitor-based anti-Helicobacter pylori treatment from one to two weeks in duodenal ulcer: is it worthwhile?
    Maconi G; Russo A; Imbesi V; Cucino C; Bianchi Porro G
    Dig Liver Dis; 2000 May; 32(4):275-80. PubMed ID: 11515622
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.